Literature DB >> 12831290

Vitreous haemorrhage in elderly patients: management and prevention.

Kaykhosrov Manuchehri1, Graham Kirkby.   

Abstract

Vitreous haemorrhage can be caused by a disruption of normal retinal vessels, bleeding from diseased retinal vessels, bleeding from abnormal new vessels or extension of haemorrhage through the retina from other sources. In the elderly, vitreous haemorrhage usually occurs spontaneously and only occurs occasionally as a result of trauma. Appropriate management of vitreous haemorrhage is dependent on the most likely cause in a particular patient. As always, an accurate medical history with a careful clinical examination, static and dynamic ultrasonography performed by an experienced examiner, results of other laboratory tests and an understanding of the common causes of vitreous haemorrhage in each age group is essential to come to a 'best guess' diagnosis as to the cause of the vitreous haemorrhage and thus guide the physician toward the appropriate management. Immediate surgical removal of blood if indicated, as well as improving the vision gives the added benefit of allowing a full examination of the underlying retina. For those in whom surgical removal of blood is not recommended, a careful and frequent follow-up with serial B-scan ultrasound allows the 'best guess' diagnosis to be confirmed at each visit, until such time as the vitreous haemorrhage resolves sufficiently to allow a full and proper examination of the retina. Where there is a confirmed retinal tear, retinal detachment or other fundal pathology these are treated appropriately with laser or surgery (vitrectomy). Preventative measures are dependent on the underlying cause of vitreous haemorrhage. Some of the underlying causes such as posterior vitreous detachment cannot be prevented. In others, such as retinal vein occlusion, measures may need to be taken so as to reduce the risk of a similar event in the same or fellow eye and to reduce the risk of potentially life-threatening associated systemic conditions such as a stroke or myocardial infarction.

Entities:  

Mesh:

Year:  2003        PMID: 12831290     DOI: 10.2165/00002512-200320090-00003

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  42 in total

1.  Intraocular hemorrhage associated with dental implant surgery.

Authors:  K Krepler; A Wedrich; R Schranz
Journal:  Am J Ophthalmol       Date:  1996-11       Impact factor: 5.258

2.  The posterior vitreous detachment clinic: do new retinal breaks develop in the six weeks following an isolated symptomatic posterior vitreous detachment?

Authors:  P S Richardson; M T Benson; G R Kirkby
Journal:  Eye (Lond)       Date:  1999-04       Impact factor: 3.775

3.  Vitreous hemorrhage following retrobulbar anesthesia.

Authors:  P F Labelle; A Lapointe; M C Boucher
Journal:  Can J Ophthalmol       Date:  1996-02       Impact factor: 1.882

4.  Presumed choroidal granuloma with vitreous hemorrhage resembling choroidal melanoma.

Authors:  K Gündüz; C L Shields; J A Shields; H Schubert
Journal:  Ophthalmic Surg Lasers       Date:  1998-05

5.  Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy.

Authors:  J F West; Z J Gregor
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

6.  Management of postvitrectomy diabetic vitreous hemorrhage with tissue plasminogen activator (t-PA) and volume homeostatic fluid-fluid exchanger.

Authors:  W C Wu; S M Chang; J Y Chen; C W Chang
Journal:  J Ocul Pharmacol Ther       Date:  2001-08       Impact factor: 2.671

7.  Vitreous hemorrhage after intravitreal tissue plasminogen activator (t-PA) and pneumatic displacement of submacular hemorrhage.

Authors:  G T Kokame
Journal:  Am J Ophthalmol       Date:  2000-04       Impact factor: 5.258

8.  Natural history of posterior vitreous detachment with early management as the premier line of defense against retinal detachment.

Authors:  N E Byer
Journal:  Ophthalmology       Date:  1994-09       Impact factor: 12.079

9.  Repetitive low-dose tissue plasminogen activator for the clearance of experimental vitreous hemorrhage.

Authors:  W K Min; Y B Kim; B H Ahn; G H Seong
Journal:  Korean J Ophthalmol       Date:  1994-12

10.  Diabetes mellitus and retinal vein occlusion in patients of Asian, west Indian and white European origin.

Authors:  P M Dodson; E E Kritzinger; C G Clough
Journal:  Eye (Lond)       Date:  1992       Impact factor: 3.775

View more
  1 in total

Review 1.  Ocular associations of diabetes other than diabetic retinopathy.

Authors:  V Swetha E Jeganathan; Jie Jin Wang; Tien Yin Wong
Journal:  Diabetes Care       Date:  2008-09       Impact factor: 19.112

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.